(Bloomberg) -- Canadian cannabis brands are having a tough time getting consumers to notice them.
No brand in Canada has more than 41% recognition among current cannabis users, with most languishing between 1% and 15%, according to a survey of 3,000 consumers conducted by pot data firm Brightfield Group.
Even those that attract the most attention aren’t converting that awareness into purchases. While Canopy Growth Corp.’s Tweed and Aurora Cannabis Inc.’s Drift have the widest brand awareness at 41% and 34% respectively, less than half of consumers familiar with those brands actually go out and buy them, according to Brightfield’s report.
“Industry players have primarily focused on raising capital, but this has not inherently translated into strong customer relationships,” the report says. “As the market becomes more consumer-centric, brands must focus on developing a deep understanding of the competitive landscape and consumer behavior to stay relevant and ensure they don’t risk being seen as a commodity.”
Unlike more mature consumer markets, the brands that attract the highest levels of satisfaction aren’t necessarily those with the most awareness either.
Tilray Inc.’s Canaca, for example, has very low consumer awareness at 9% but those who buy it tend to love it, with 97% reporting overall satisfaction and 99% saying they’re likely to purchase again. Tweed, by comparison, has an 89% overall satisfaction score and 90% are likely to buy it again.
What does this mean for Canadian cannabis companies, according to Brightfield? “For now, it’s anyone’s game.”
A U.S. Food and Drug Administration study of CBD products shows the category is still very much the Wild West.
Of the 102 products studied that indicated a specific amount of CBD, less than half came within 20% of the amount promised. Meanwhile, 37% had more than 120% of the amount indicated and 18% contained less than 80% of the advertised amount, according to the FDA.
Perhaps most troubling for those consumers who choose CBD because they’re not comfortable with its psychoactive cousin THC, 49% of the products tested contained some measurable amount of THC or the closely related compound THCA.
Events This Week
- WeedMD Inc. reports earnings after market close
- Valens Co. and Flower One Holdings Inc. release results postmarket
- Cowen & Co. holds a cannabis policy summit featuring presentations by Canopy, Curaleaf Holdings Inc., Green Thumb Industries Inc. and others
Last Week’s Top Stories
Uruguay to Cut Red Tape to Speed Up Cannabis Exports: Official
New Jersey Voters May Ignite a Northeast Pot Party in November: Bloomberg Intelligence
Canadian Cannabis Producers’ Pivot to Profits Will Be 2Q Focus: Bloomberg Intelligence
©2020 Bloomberg L.P.